# Remote Assessment of OCT Scans for BCC Detection

> **NCT06273709** · — · UNKNOWN · sponsor: **Maastricht University Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

- **DEVICE:** Vivosight Multi-beam Swept-Source Frequency Domain OCT scanner

## Key facts

- **NCT ID:** NCT06273709
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273709, "Remote Assessment of OCT Scans for BCC Detection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06273709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*